Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma

BACKGROUND: Use of statins is associated with a reduced risk of hepatocellular carcinoma (HCC). However, the effect of statin use on HCC recurrence is unclear. This study aimed to evaluate the effect of statin use on recurrence after curative resection among patients with HCC. METHODS: We retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shih-Yu, Wang, Chih-Chi, Chen, Kuang-Den, Liu, Yueh-Wei, Lin, Chih-Che, Chuang, Ching-Hui, Tsai, Yu-Chieh, Yao, Chih-Chien, Yen, Yi-Hao, Hsiao, Chang-Chun, Hu, Tsung-Hui, Tsai, Ming-Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808883/
https://www.ncbi.nlm.nih.gov/pubmed/33446127
http://dx.doi.org/10.1186/s12885-021-07796-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808883/
https://www.ncbi.nlm.nih.gov/pubmed/33446127
http://dx.doi.org/10.1186/s12885-021-07796-7

Ejemplares similares